Details for New Drug Application (NDA): 050554
✉ Email this page to a colleague
NDA 050554 describes PRECEF, which is a drug marketed by Apothecon and Bristol and is included in two NDAs. Additional details are available on the PRECEF profile page.
The generic ingredient in PRECEF is ceforanide. There is one drug master file entry for this compound. Additional details are available on the ceforanide profile page.
The generic ingredient in PRECEF is ceforanide. There is one drug master file entry for this compound. Additional details are available on the ceforanide profile page.
Summary for 050554
| Tradename: | PRECEF |
| Applicant: | Bristol |
| Ingredient: | ceforanide |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 500MG/VIAL | ||||
| Approval Date: | May 24, 1984 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1GM/VIAL | ||||
| Approval Date: | May 24, 1984 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2GM/VIAL | ||||
| Approval Date: | May 24, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
